Elevance Health, Inc. reported its financial results for the first quarter of 2026, revealing total revenues of $50.2 billion, a 2.6% increase from $48.9 billion in the same period last year. The company's operating revenue rose to $49.5 billion, up from $48.8 billion, primarily driven by premium rate increases in its Health Benefits segment and growth in CarelonRx product revenues. However, net income for the quarter decreased by 19.2% to $1.76 billion, compared to $2.18 billion in the prior year, largely due to increased operating expenses and interest costs.
The company's total assets increased to $125.8 billion as of March 31, 2026, up from $121.5 billion at the end of 2025. This growth was supported by a rise in cash and cash equivalents, which reached $9.66 billion, compared to $9.49 billion at the end of the previous year. Elevance Health's medical membership stood at approximately 45.4 million, a slight decline of 0.9% from the previous year, attributed mainly to attrition in Medicaid membership and decreases in Medicare Advantage and Employer Group Risk-Based segments.
In terms of operational developments, Elevance Health initiated a strategic transformation program aimed at streamlining decision-making and enhancing technology use across the organization. This program is expected to involve targeted workforce reductions and modernization of IT platforms, with costs incurred in the first quarter amounting to $129 million. The company also reported a significant increase in cash flow from operations, which rose to $4.33 billion from $1.02 billion in the prior year, reflecting favorable working capital impacts.
Looking ahead, Elevance Health anticipates continued challenges in the healthcare landscape, including elevated medical cost trends and regulatory changes. The company is focused on improving its operational efficiency and maintaining its competitive position in the market. The outlook for the remainder of 2026 remains cautious, with expectations of ongoing adjustments in pricing strategies and membership dynamics, particularly in the Medicare and Medicaid sectors.
About Elevance Health, Inc.
Elevance Health is a leading U.S. health company providing managed care health insurance, pharmacy, and healthcare services. Its core segments include health benefits, pharmacy services, and integrated care delivery, serving individuals, employers, and government programs like Medicare and Medicaid. The company leverages extensive provider networks, value-based care models, and innovative digital tools to improve healthcare quality, affordability, and access across diverse markets.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.